Suppr超能文献

[用于呼吸道标本中结核分枝杆菌复合群快速鉴定的自动化RNA扩增]

[Automated RNA amplification for the rapid identification of Mycobacterium tuberculosis complex in respiratory specimens].

作者信息

Drouillon V, Houriez F, Buze M, Lagrange P, Herrmann J-L

机构信息

Service de microbiologie, hôpital Saint-Louis, 1 avenue Claude-Vellefaux, 75010 Paris, France.

出版信息

Pathol Biol (Paris). 2006 Oct-Nov;54(8-9):518-22. doi: 10.1016/j.patbio.2006.07.041. Epub 2006 Oct 5.

Abstract

Rapid and sensitive detection of Mycobacterium tuberculosis complex (MTB) directly on clinical respiratory specimens is essential for a correct management of patients suspected of tuberculosis. For this purpose PCR-based kits are available to detect MTB in respiratory specimen but most of them need at least 4 hours to be completed. New methods, based on TRC method (TRC: Transcription Reverse transcription Concerted--TRCRapid M. Tuberculosis--Tosoh Bioscience, Tokyo, Japon) and dedicated monitor have been developed. A new kit (TRC Rapid M. tuberculosis and Real-time monitor TRCRapid-160, Tosoh Corporation, Japan) enabling one step amplification and real-time detection of MTB 16S rRNA by a combination of intercalative dye oxazole yellow-linked DNA probe and isothermal RNA amplification directly on respiratory specimens has been tested in our laboratory. 319 respiratory specimens were tested in this preliminary study and results were compared to smear and culture. Fourteen had a positive culture for MTB. Among theses samples, smear was positive in 11 cases (78.6%) and TRC process was positive in 8 cases (57.1%). Overall sensitivity of TRC compared to smear positive samples is 73%. Theses first results demonstrated that a rapid identification of MTB was possible (less than 2 processing hours for 14 specimens and about 1 hour for 1 specimen) in most cases of smear positive samples using ready to use reagents for real time detection of MTB rRNA in clinical samples. New pretreatment and extraction reagents kits to increase the stability of the sputum RNA and the extraction efficiency are now tested in our laboratory.

摘要

直接在临床呼吸道标本上快速、灵敏地检测结核分枝杆菌复合群(MTB)对于正确管理疑似结核病患者至关重要。为此,有基于PCR的试剂盒可用于检测呼吸道标本中的MTB,但大多数试剂盒至少需要4小时才能完成检测。基于TRC方法(TRC:转录逆转录协同——TRC快速结核杆菌——日本东京东曹生物科学公司)和专用监测仪开发了新方法。一种新试剂盒(TRC快速结核杆菌和实时监测仪TRCRapid - 160,日本东曹公司),通过结合插入染料恶唑黄连接的DNA探针和等温RNA扩增,能够在呼吸道标本上一步扩增并实时检测MTB 16S rRNA,已在我们实验室进行了测试。在这项初步研究中对319份呼吸道标本进行了检测,并将结果与涂片和培养结果进行了比较。14份标本MTB培养呈阳性。在这些样本中,11例(78.6%)涂片呈阳性,8例(57.1%)TRC检测呈阳性。与涂片阳性样本相比,TRC的总体灵敏度为73%。这些初步结果表明,在大多数涂片阳性样本中,使用即用型试剂实时检测临床样本中的MTB rRNA,有可能快速鉴定MTB(14份标本处理时间少于2小时,1份标本约1小时)。我们实验室目前正在测试新的预处理和提取试剂试剂盒,以提高痰液RNA的稳定性和提取效率。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验